Drug Trial Radar · NCT05355974
Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure
Last checked: Nov 19, 2026Latest source record: Jul 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
42
Actual
Start
Aug 9, 2022
Primary completion
Jul 10, 2024
Study completion Jul 10, 2024
Sponsor
- Lead sponsor
- Wright State UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate whether protocolized vasopressor use for patients with normal blood pressure undergoing rapid sequence intubation improves hemodynamic parameters and mitigates adverse events. The hypothesis is that use of vasopressors during Rapid Sequence Intubation will prevent substantial decreases in blood pressure when compared to normal intravenous fluids.
Conditions
- Respiratory Failure
- Hypotension and Shock
- Hypotension on Induction
- Intubation Complication
- Anesthesia Intubation Complication
Interventions
NorepinephrineDrug
Norepinephrine continuous infusion at 0.10 mcg/kg/min
Lactated Ringers, IntravenousDrug
500mL infusion run at 999mL/hr
normal salineDrug
500mL infusion run at 999mL/hr
Plasma-lyteDrug
500mL infusion run at 999mL/hr
Primary outcomes
What the sponsor says the trial is designed to measure.
- Systolic Blood PressureTime frame: 1 hour after Rapid Sequence Intubation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Miami Valley Hospital Premier Health
Dayton, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.